ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

XTLB XTL Biopharmaceuticals Ltd

2.64
-0.01 (-0.38%)
May 31 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -249k-202k-204k-225k-251k-163k-151k-200k
Pre Tax Income 506k-285k-821k-748k-919k-364k-215k-284k
Net Income 72k149k-821k-748k-919k-364k-215k-284k
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -249k-202k-204k-225k-251k-163k-151k-200k
EBITDA -249k-202k-204k-224k-251k-163k-151k-200k
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -2.56M-1.24M-793k-842k-948k-1.03M-880k-765k
Pre Tax Income -2.55M-781k2.99M-1.35M-782k435k-1.35M-1.78M
Net Income -2.55M-781k2.99M-1.35M-782k435k-1.35M-1.78M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.008-0.0010.005-0.002-0.0010.001-0.002-0.003
EBIT -2.56M-1.25M-793k-842k-948k-1.03M-880k-765k
EBITDA -1.71M-1.24M-793k-842k-947k-1.03M-879k-765k